Chemical Component Summary

NameTRAZEOLIDE
Identifiers4-oxo-4-[(2S,3S)-1,1,2,6-tetramethyl-3-propan-2-yl-2,3-dihydroinden-5-yl]butanoic acid
FormulaC20 H28 O3
Molecular Weight316.44
TypeNON-POLYMER
Isomeric SMILESCC(C)[C@H]1[C@H](C)C(C)(C)c2cc(C)c(cc12)C(=O)CCC(O)=O
InChIInChI=1S/C20H28O3/c1-11(2)19-13(4)20(5,6)16-9-12(3)14(10-15(16)19)17(21)7-8-18(22)23/h9-11,13,19H,7-8H2,1-6H3,(H,22,23)/t13-,19-/m0/s1
InChIKeyYUTXECPABXNXPU-DJJJIMSYSA-N

Chemical Details

Formal Charge0
Atom Count51
Chiral Atom Count2
Bond Count52
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB08647 
NameTRAZEOLIDE
Groupsexperimental
SynonymsTRAZEOLIDE

Drug Targets

NameTarget SequencePharmacological ActionActions
Ig kappa chain C regionTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGN...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682